greeksoup/ stock research

Healthstream (HSTM) FY2021 results: revenue $257 million, up 4.9% on the year

Healthstream Inc. (HSTM) reported revenue of $257 million for fiscal 2021, the year ended 31 December 2021, up 4.9% on the year before. Net income was $6 million, down 58.5%, and diluted earnings per share $0.18. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2022.

Revenue
$257 million
+4.9% on the year
FY2014FY2021
Operating margin
3.1%
6.5% a year earlier
FY2014FY2021
Net income
$6 million
-58.5% on the year
FY2014FY2021
Diluted EPS
$0.18
-59.1% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q3 FY2021 · Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue257245254+4.9%
Cost of revenue91.089.3104+1.9%
Gross profit166155150+6.6%
Gross margin64.5%63.5%59.1%
Research and development41.732.329.1+29.0%
Operating income8.115.814.7-49.1%
Operating margin3.1%6.5%5.8%
Pre-tax income7.817.817.9-56.4%
Income tax1.93.73.7-48.5%
Effective tax rate24.7%20.9%20.8%
Net income5.814.115.8-58.5%
Net margin2.3%5.8%6.2%
Diluted EPS$0.18$0.44$0.49-59.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow42.435.965.7+18.1%
Capital expenditure3.42.022.0+71.9%
Free cash flow39.033.943.7+15.0%
Free cash flow margin15.2%13.8%17.2%
Cash from investing-25.7-110-67.5
Cash from financing-6.2-20.5-0.9
Depreciation and amortisation36.830.227.9+21.9%
Share-based compensation5.32.24.2+139.2%
Buybacks5.020.00.0-75.0%
Dividends paid0.00.00.1-52.5%
Dividend per share$0.00n/an/a
Diluted shares, weighted32m32m32m-1.2%
Shares outstanding at period end31m31m32m-0.6%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity339334338+1.5%
Debt0.00.00.0
Operating lease liabilities26.228.530.7-8.1%
Other liabilities122138121-11.8%
Total liabilities and equity487500490-2.7%
Fixed assets17.922.226.1-19.2%
Goodwill183178102+2.3%
Intangible assets89.210160.1-11.4%
Investments5.09.941.3-49.2%
Cash and equivalents46.936.6132+28.3%
Receivables30.340.727.6-25.6%
Other assets115112101+2.8%
Total assets487500490-2.7%

10-K for the year ended 31 December 2021, filed 28 February 2022: the filing.